Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs
Autore:
Halpenny, M; Markos, F; Snow, HM; Duggan, PF; Gaffney, E; OConnell, DP; Shorten, GD;
Indirizzi:
Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland Natl Univ Ireland Univ Coll Cork Cork Ireland s Care Med, Cork, Ireland
Titolo Testata:
EUROPEAN JOURNAL OF ANAESTHESIOLOGY
fascicolo: 8, volume: 17, anno: 2000,
pagine: 491 - 498
SICI:
0265-0215(200008)17:8<491:TEOFOR>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
LOW-DOSE DOPAMINE; RECEPTOR AGONIST; SURGERY; HEMODYNAMICS; EXCRETION; ANEURYSM; HUMANS;
Keywords:
abdominal aorta, clamping; receptor agonist, dopamine; fenoldopam; failure, renal;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
34
Recensione:
Indirizzi per estratti:
Indirizzo: Halpenny, M 3 Waltham,Clonfadda Wood,Mt Merrion Ave, Blackrock, Co Dublin,Ireland 3 Waltham,Clonfadda Wood,Mt Merrion Ave Blackrock Co Dublin Ireland
Citazione:
M. Halpenny et al., "The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs", EUR J ANAES, 17(8), 2000, pp. 491-498

Abstract

Postoperative renal impairment is a recognized complication of infrarenal aortic cross-clamping. Fenoldopam, a selective dopamine agonist, may increase renal blood flow and decrease tubular oxygen consumption. The objective of this study was to quantify the effects of fenoldopam (0.1 mu g kg(-1) min(-1)) on renal blood flow and renal tubular function in anaesthetized dogsthat have undergone aortic cross clamping. Eight labrador dogs were selected to receive either saline or fenoldopam (0.1 mu g kg(-1) min(-1)) intravenously. Arterial pressure, heart rate, renal blood flow, urinary output, fractional excretion of sodium, creatinine clearance and lithium clearance were measured (a) prior to infusions of saline or fenoldopam (b) 1 h after commencing the infusion (c) during a 90-min period of infrarenal aortic cross-clamping with concurrent infusion of fenoldopam or saline and (d) for 1 h after simultaneous aortic declamping and discontinuation of the infusions. There was no haemodynamic instability upon commencing the infusion of fenoldopam (0.1 mu g kg(-1) min(-1)). Creatinine clearance (2.03+/-0.5-2.45+/-0.3 mL min(-1) kg(-1) (mean+/-SD)), urine output (0.23+/-0.16-0.35+/-0.23 mL min(-1) (mean+/-SD)), and fractional excretion of sodium (0.7+/-0.52-1.3+/-0.73%(mean+/-SD)) increased (P < 0.05), following commencement of the fenoldopam infusion. Fractional excretion of sodium (1.2+/-0.7% (mean+/-SD)) andurine output (0.36+/-0.21 mL min(-1) (mean+/-SD)) were maintained during the aortic cross-clamp period (P < 0.05). Renal blood flow increased when the fenoldopam infusion was commenced (145+/-43.3-161+/-39.2 mL min(-1) (mean/-SD)) and remained greater than baseline during the aortic cross-clampingperiod (152+/-44 mL min(-1) (mean+/-SD)), although these increases did notreach statistical significance. The mast striking abnormalities observed by electron microscopy were marked disruption of the microvillus brush border in proximal tubules, vacuolation and separation of epithelial cells on basolateral infolds. The changes were similar in the two groups. In conclusion fenoldopam (0.1 mu g kg(-1) min(-1)) may have renoprotective effects which persist during infrarenal aortic cross clamping.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/03/20 alle ore 00:46:31